Upfront Ezetimibe in ACS; New Watchman LAA Occluder OK'd; Low-Cost FH Genotyping

(MedPage Today) -- Compared with statins alone, upfront dual therapy with a statin and ezetimibe (Zetia) was associated with better survival in acute coronary syndrome, a Polish registry showed. (Journal of the American Heart Association) What...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news